[Indications for the use of neuleptil. Review of the literature and clinical contribution].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000188:drug therapy; D000987:Antisocial Personality Disorder / Q000188:drug therapy; D002648:Child; D003704:Dementia / Q000188:drug therapy; D004827:Epilepsy / Q000150:complications; D005260:Female; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy; D009570:Nitriles / Q000627:therapeutic use*; D010259:Paranoid Disorders / Q000188:drug therapy; D010554:Personality Disorders / Q000188:drug therapy; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy; D012559:Schizophrenia / Q000188:drug therapy; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D009570:Nitriles; D010640:Phenothiazines; D010880:Piperidines; D014149:Tranquilizing Agents
Indicazioni sull'uso del neuleptil. Revisione della letteratura e contibuto clinico.